Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Clinical & Developmental Immunology|July 11, 2012
Novel anti-melanoma immunotherapies: disarming tumor escape mechanismsSivan Sapoznik, Ohad Hammer, Rona Ortenberg, et al.
Frontiers in Immunology|January 25, 2021
Genetic Modification of Tumor-Infiltrating Lymphocytes <i>via</i> Retroviral TransductionHadas Weinstein-Marom, Gideon Gross, Michal Levi, et al.
Immunotherapy|December 22, 2012
Adoptive T-cell transfer in melanomaOrit Itzhaki, Daphna Levy, Dragoslav Zikich, et al.
Frontiers in Immunology|October 26, 2017
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 SeparationSivan Seliktar-Ofir, Efrat Merhavi-Shoham, Orit Itzhaki, et al.
Frontiers in Immunology|July 28, 2020
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against LeukemiaMeir Rozenbaum, Amilia Meir, Yarden Aharony, et al.
Current Research in Translational Medicine|December 29, 2019
Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemiaIvetta Danylesko, Guy Chowers, Roni Shouval, et al.
Neoplasia (New York, N.Y.)|March 21, 2018
Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma CellsKarin Kfir-Elirachman, Rona Ortenberg, Bella Vizel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Collection of large-scale expanded lymphocyte cultures for adoptive immunotherapy using a COBE Spectra apheresis machineEster Schallmach, Rina Sareli, Michal J Besser, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating LymphocytesRonny Ben-Avi, Orit Itzhaki, David Simansky, et al.
Pageof 8